Maxwell Skor

Stock Analyst at Morgan Stanley

(n/a)
# 4,492
Out of 4,820 analysts
3
Total ratings
n/a
Success rate
-35.32%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Maxwell Skor

TScan Therapeutics
Mar 14, 2025
Assumes: Overweight
Price Target: $10
Current: $1.60
Upside: +526.96%
Invivyd
Nov 20, 2024
Maintains: Overweight
Price Target: $9.5$3.55
Current: $0.63
Upside: +461.00%